Close
Back to CBAY Stock Lookup

CymaBay Therapeutics (CBAY) – Major News

Feb 28, 2024 04:57 PM CymaBay Therapeutics (CBAY) Misses Q4 EPS by 4c
Feb 12, 2024 08:32 AM Gilead Sciences (GILD) to Acquire CymaBay Therapeutics (CBAY) for $32.50 Per Share, $4.3 Billion
Nov 7, 2023 04:04 PM CymaBay Therapeutics (CBAY) Misses Q3 EPS by 3c
Aug 10, 2023 04:05 PM CymaBay Therapeutics (CBAY) Tops Q2 EPS by 19c
May 15, 2023 04:07 PM CymaBay Therapeutics (CBAY) Misses Q1 EPS by 20c
Mar 16, 2023 04:06 PM CymaBay Therapeutics (CBAY) Reports In-Line Q4 EPS
Nov 14, 2022 04:20 PM CymaBay Therapeutics (CBAY) Tops Q3 EPS by 2c
Aug 11, 2022 04:32 PM CymaBay Therapeutics (CBAY) Misses Q2 EPS by 2c
Jul 23, 2020 08:04 AM CymaBay Therapeutics (CBAY) Announces FDA Lifts All Clinical Holds on Seladelpar
Aug 7, 2019 05:16 PM CymaBay Therapeutics (CBAY) Tops Q2 EPS by 2c
Mar 15, 2018 04:03 PM CymaBay Therapeutics (CBAY) Tops Q4 EPS by 8c, Beats on Revenues
Nov 8, 2017 04:29 PM CymaBay Therapeutics (CBAY) Misses Q3 EPS by 2c
Jan 3, 2017 04:02 PM CymaBay Therapeutics (CBAY) Enters Exclusive Licensing Deal with Kowa Pharmaceuticals for Arhalofenate in the U.S.
Nov 12, 2015 04:29 PM CymaBay Therapeutics (CBAY) Tops Q3 EPS by 6c
Aug 10, 2015 05:15 PM CymaBay Therapeutics (CBAY) Tops Q2 EPS by 33c
Mar 18, 2015 04:24 PM CymaBay Therapeutics (CBAY) Misses Q4 EPS by 40c
Nov 12, 2014 04:24 PM CymaBay Therapeutics (CBAY) Tops Q3 EPS by 3c

Back to CBAY Stock Lookup